## TER: Teradyne, Inc. - XLK: Technology

### Executive Summary

STRENGTH thesis confirmed: MRS_10 at 4.7% in mid entry zone (3.0-6.0%), top 8% cross-sectional ranking. Short-term MRS_5 (0.1%) confirms momentum alignment. Outperforming sector by 3.4%. Caution: momentum weakening (-5.0% MRS).

- **Horizon:** 5-20 days (swing)
- **Risk Profile:** Moderate - momentum continuation
- **Stop Type:** Fixed 2xATR ($184.63)
- **If Wrong:** Exit if MRS_10 drops below entry zone or breaks stop
- **Invalidation:** MRS_10 exits entry zone or MRS_5 turns negative

### News

- **Articles:** 10
- **Sentiment:** Bullish (Bullish: 7, Bearish: 0)

**1. Teradyne (NASDAQ: TER) plans 2026 Michigan robotics hub to make UR cobots, create over 200 jobs**
- Source: Stock Titan | 20251209T150440 | Bullish | Relevance: 99%
-  Teradyne Robotics (NASDAQ: TER) announced it will open a new U.S. Operations Hub in Wixom, Metro Detroit, Michigan in 2026. This facility will manufacture Universal Robots industrial collaborative robots and potentially MiR autonomous mobile robots, creating over 200 jobs. The hub will also serve as a customer training center, service hub, and visitor experience center, supporting U.S. industrial growth and addressing workforce challenges through robotics.

**2. TER (Teradyne) Other Gross PPE : $632 Mil (As of Sep. 2025)**
- Source: GuruFocus | 20251208T040945 | Neutral | Relevance: 99%
-  As of September 2025, Teradyne's Other Gross PPE stood at $632 million, showing an increasing trend quarter-over-quarter from March 2025. Annually, this figure increased from December 2022 to December 2023, then slightly declined by December 2024. The data highlights Teradyne's investment in property, plant, and equipment within its semiconductor and industrial automation sectors.

**3. Teradyne Surges 129% in Six Months: Is the Stock Worth a Buy?**
- Source: Finviz | 20251209T180838 | Bullish | Relevance: 98%
- Teradyne (TER) shares have surged 129.2% in the past six months, outperforming its sector and peers, driven by strong AI-related demand and an expanding portfolio in semiconductor testing and robotics. The company's innovative products like the ETS-800 D20 and UltraPHY 224G, coupled with its focus on AI-driven robotics, position it for continued growth, although its current valuation appears premium. Despite being overvalued based on Price/Sales, Zacks Investment Research recommends accumulating the stock due to its robust prospects.

**4. (TER) Price Dynamics and Execution-Aware Positioning**
- Source: Stock Traders Daily | 20251207T120400 | Somewhat-Bullish | Relevance: 98%
- This article provides an in-depth analysis of Teradyne Inc. (NYSE: TER) focusing on price dynamics and execution-aware positioning based on AI models. It highlights strong sentiment across all horizons supporting an overweight bias, outlines three distinct trading strategies (Position, Momentum Breakout, and Risk Hedging), and presents a multi-timeframe signal analysis. The report also notes the current price in relation to support and resistance levels.

**5. 5-Day Rally Sends Teradyne Stock Up 13%**
- Source: Trefis | 20251209T045349 | Bullish | Relevance: 98%
-  Teradyne stock has seen a significant 13% increase over a five-day rally. This information is presented within the context of Trefis financial data and platform features.

### Analyst Activity

**Target Signal:** VERY_BULLISH (Raises: 2, Lowers: 0)

| Date | Firm | Target | Prior | Change |
|------|------|--------|-------|--------|
| 2025-12-02 | Stifel | $225 | $162 | +39% |
| 2025-11-12 | Citigroup | $215 | $117 | +84% |

**Rating Changes:**

| Date | Firm | Action | Grade |
|------|------|--------|-------|
| 2025-12-02 | Stifel | up | Buy |
| 2025-11-12 | Citigroup | main | Buy |

### Insider Activity (90 days)

| Metric | Value |
|--------|-------|
| Direction | **NET_SELLING** |
| Buys | 7 ($0.08M) |
| Sells | 6 ($0.70M) |

### Institutional Ownership

| Metric | Value |
|--------|-------|
| Total Ownership | 44.3% |
| Smart Money | **BULLISH** |
| Net Flow | 0.0% |
| Buying/Selling | 8 / 2 |

**Top Holders:**
- Vanguard Group Inc: 12.3% (+2.1%)
- Blackrock Inc.: 8.4% (-7.2%)
- JPMORGAN CHASE & CO: 5.4% (+126.5%)
- State Street Corpora: 4.0% (+0.3%)
- Ameriprise Financial: 3.0% (+6.8%)

### Key Risks

1. High beta (1.85) amplifies market volatility - any risk-off move could trigger sharp selloff.
2. Market regime shift could impact high-beta names disproportionately.
3. Sector rotation risk if leadership changes from current market theme.

### Catalysts

- Broader market risk-on sentiment could lift quality names.
- Year-end positioning and window dressing may support price.

### Fundamentals

PEG ratio 1.64 elevated, pricing in significant growth expectations. Forward P/E 39.2x attractive for 45% earnings growth. Quality metrics strong (margin 16%). Balance sheet: low leverage (D/E 0.46). Revenue growth strong at 23% YoY. Analyst sentiment positive (2 raises, avg +61%). Institutional flow bullish (8 buying vs 2 selling).

| Metric | Value |
|--------|-------|
| Market Cap | $31.8B |
| Beta | 1.85 |
| 52W Range | $65.77 - $205.00 |
| Short Interest | 4.2% |

| Valuation | Value |
|-----------|-------|
| PEG Ratio | 1.64 |
| Forward P/E | 39.2 |
| Current P/E | 56.8 |
| YoY Growth | 45.1% |
| EPS Direction | RISING |

### Technicals

MRS_10 deteriorating from 9.7% to 4.7% (-5.0% in 5 days), indicating relative weakness vs NASDAQ. Currently in upper STRENGTH zone (3.0-6.0%), cross-sectional ranking at 91st percentile. MRS_5 at 0.1% confirms short-term momentum alignment. Outperforming sector by 3.4pp, stock-specific strength. Full SMA alignment bullish (above 20/50/200 SMAs). MACD histogram positive (2.25), confirming momentum.

| Metric | Value | Signal |
|--------|-------|--------|
| MRS_10 | 4.70% (CS: 92) | Strong |
| RSI_14 | 68.1 | Neutral |
| MACD Histogram | 2.25 | Bullish |
| vs SMA20 | 1.120x | Above |
| vs SMA50 | 1.223x | Above |
| vs SMA200 | 1.787x | Above |

### Decision

- **Verdict:** AVOID
- **Thesis:** STRENGTH

### Trade Setup

- **Entry:** $199.97
- **Stop Loss:** $184.63 (7.7% risk)
- **Target:** $222.98 (R:R method)
- **Risk/Reward:** 1.50:1
- **Target Reasoning:** STRENGTH thesis targets 1.5x risk/reward based on historical edge

### Position Sizing

- **Shares:** 78
- **Position Value:** $15,597.66
- **Portfolio %:** 15.60%
- **Risk Dollars:** $1,200.00
- **Risk Per Trade:** 1.20%
- **Modifiers:** L1 100% | L2 120% | Combined 1.20x

### Market Context

| Layer | Signal | Modifier |
|-------|--------|----------|
| L1 Macro | NORMAL (MEDIUM) | 1.00x |
| L2 Sector | TREND (Zone A) | 1.20x |

*NORMAL regime with moderate risk appetite. VIX remains in the mid-range, breadth is moderate, and yield curve is flat but not invertedâ€”indicating standard late-cycle conditions. Upbeat earnings and positive tech momentum are offset by cautious guidance in consumer sectors, suggesting selective positioning is favored.*

### Earnings

**Next:** 2026-01-28 (Est: $1.36)

| Quarter | Est | Actual | Surprise |
|---------|-----|--------|----------|
| 2025Q3 | $0.79 | $0.85 | +7.4% |
| 2025Q2 | $0.54 | $0.57 | +4.9% |
| 2025Q1 | $0.62 | $0.75 | +21.7% |
| 2024Q4 | $0.91 | $0.95 | +4.5% |

---
*RULE-based L3 | 2026-01-06 16:37 | MRS_10*